Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Irfan Manji, Tanita Cepalo, Sergio Ledesma & Pascal Fallavollita. (2023) Personhood, QOL, and Well-being in People with Dementia undergoing Creative Arts-based Therapies: A Scoping Review. Creativity Research Journal 0:0, pages 1-23.
Read now
Read now
Sajed Mangoo, Simon Erridge, Carl Holvey, Ross Coomber, Daniela A Riano Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, James J Rucker & Mikael H Sodergren. (2022) Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry. Expert Review of Neurotherapeutics 22:11-12, pages 995-1008.
Read now
Read now
Serafim Carvalho, Filipa Caetano, José Pinto-Gouveia, Jorge Mota-Pereira, Dulce Maia, Paulo Pimentel, Cátia Priscila & Paul Gilbert. (2021) Predictors of poor 6-week outcome in a cohort of major depressive disorder patients treated with antidepressant medication: the role of entrapment. Nordic Journal of Psychiatry 75:1, pages 38-48.
Read now
Read now
Gregory M Asnis & Margaret A Henderson. (2014) EMSAM (deprenyl patch): how a promising antidepressant was underutilized. Neuropsychiatric Disease and Treatment 10, pages 1911-1923.
Read now
Read now
Rita Moretti, Elena Bernobich, Francesca Esposito, Paola Torre, Rodolfo M Antonello, Luisa De Angelis & Giuseppe Bellini. (2011) Depression in vascular pathologies: the neurologist’s point of view. Vascular Health and Risk Management 7, pages 433-443.
Read now
Read now
J Craig Nelson, Andrei Pikalov & Robert M Berman. (2008) Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatric Disease and Treatment 4:5, pages 937-948.
Read now
Read now
Fabrice Duval, Barry D. Lebowitz & Jean-Paul Macher. (2006) Treatments in depression. Dialogues in Clinical Neuroscience 8:2, pages 191-206.
Read now
Read now
Articles from other publishers (34)
Vern Lewis, Brandon Rodrigue, Emily Arsenault, Molly Zhang, Fatimeh‐Frouh Taghavi‐Abkuh, Weverton Castro Coelho Silva, Mysa Myers, Edna Matta‐Camacho & Argel Aguilar‐Valles. (2022) Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders. Journal of Neurochemistry 166:1, pages 10-23.
Crossref
Crossref
Preeti Garg, Jyoti Alambayan & Vandana Garg. (2023) Herbal Approaches in the Management of Mental Depression. CNS & Neurological Disorders - Drug Targets 22:1, pages 98-124.
Crossref
Crossref
Nikolaj Travica, Scott Teasdale & Wolfgang Marx. (2023) Nutraceuticals in mood disorders: current knowledge and future directions. Current Opinion in Psychiatry 36:1, pages 54-59.
Crossref
Crossref
Kirti Agrawal, Pratik Chakraborty, Saikat Dewanjee, Saniya Arfin, Sabya Sachi Das, Abhijit Dey, Mahmoud Moustafa, Prabhu Chandra Mishra, Seid Mahdi Jafari, Niraj Kumar Jha, Saurabh Kumar Jha & Dhruv Kumar. (2023) Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neuroscience & Biobehavioral Reviews 144, pages 104955.
Crossref
Crossref
Shvetank Bhatt, Thangaraj Devadoss, Niraj Kumar Jha, Moushumi Baidya, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh & Kamal Dua. (2022) Targeting inflammation: a potential approach for the treatment of depression. Metabolic Brain Disease 38:1, pages 45-59.
Crossref
Crossref
Sujita Kumar Kar & Vikas Menon. (2021) Early augmentation by using neuromodulation in psychiatric disorder: a kaleidoscopic view. CNS Spectrums 27:5, pages 530-532.
Crossref
Crossref
Sarah Sharman Moser, Gabriel Chodick, Shulamit Gelerstein, Nava Barit Ben David, Varda Shalev & Orit Stein-Reisner. (2022) Epidemiology of treatment resistant depression among major depressive disorder patients in Israel. BMC Psychiatry 22:1.
Crossref
Crossref
Qingyue Yu, Zihao Wang, Zeyu Li, Xuejun Liu, Fredrick Oteng Agyeman & Xinxing Wang. (2022) Hierarchical Structure of Depression Knowledge Network and Co-word Analysis of Focus Areas. Frontiers in Psychology 13.
Crossref
Crossref
Roberta Cassano, Camilla Servidio & Sonia Trombino. (2021) Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases. Materials 14:7, pages 1802.
Crossref
Crossref
Emily Arsenault, Aisha Asad Ahmed, Ayeila Daneshmend, Zeynep Jihad-Mohamad, Edna Matta-Camacho, Melissa Nyveld, Fatimeh-Frouh Taghavi-Abkuh, Molly Zhang, Nahum Sonenberg, Jean-Claude Lacaille & Argel Aguilar-Valles. 2021. The Neuroscience of Depression. The Neuroscience of Depression
79
88
.
Jennifer Apolinário-Hagen, Marie Drüge, Severin Hennemann & Bernhard Breil. 2021. Major Depressive Disorder. Major Depressive Disorder
311
332
.
Bernardo Dell’Osso, Umberto Albert, Giuseppe Carrà, Maurizio Pompili, Maria Giulia Nanni, Massimo Pasquini, Nicola Poloni, Andrea Raballo, Fabio Sambataro, Gianluca Serafini, Caterina Viganò, Koen Demyttenaere, Roger S. McIntyre & Andrea Fiorillo. (2020) How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist. Annals of General Psychiatry 19:1.
Crossref
Crossref
Saeed Farooq, Surrendra P Singh, Danielle Burke, Farooq Naeem & Muhammad Ayub. (2020) Pharmacological interventions for prevention of depression in high risk conditions: Systematic review and meta-analysis.. Journal of Affective Disorders 269, pages 58-69.
Crossref
Crossref
Dan Dong, Ting Lei, Meiying Song, Lijiang Ma & Hua Zhao. (2020) RETRACTED: The antidepressant effects of L-arginine on chronic mild stress-induced depression by augmenting the expression of brain-derived neurotrophic factor in rats. Brain Research Bulletin 158, pages 128-134.
Crossref
Crossref
Susan Westfall & Giulio Maria Pasinetti. (2019) The Gut Microbiota Links Dietary Polyphenols With Management of Psychiatric Mood Disorders. Frontiers in Neuroscience 13.
Crossref
Crossref
Peggy Bosch, Sabina Lim, Heike Staudte, Sook-Hyun Lee, Sujung Yeo, Daniela Litscher, Gerhard Litscher, Lu Wang & Maurits van den Noort. (2019) Geschlechtsunterschiede bei der Akupunkturbehandlung von Patienten mit DepressionenGender Differences in the Acupuncture Treatment of Patients with Depression. Deutsche Zeitschrift für Akupunktur 62:3, pages 160-165.
Crossref
Crossref
Karissa M. Johnston, Lauren C. Powell, Ian M. Anderson, Shelagh Szabo & Stephanie Cline. (2019) The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature. Journal of Affective Disorders 242, pages 195-210.
Crossref
Crossref
Jörg Mahlich, Sunny Tsukazawa & Frank Wiegand. (2017) Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study. Drugs - Real World Outcomes 5:1, pages 35-43.
Crossref
Crossref
Roland Ricken, Sven Ulrich, Peter Schlattmann & Mazda Adli. (2017) Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression. European Neuropsychopharmacology 27:8, pages 714-731.
Crossref
Crossref
Oliver G. Bosch & Barbara Breitenstein. (2015) Biomarker in der Depressionsbehandlung: mehr als nur Worte?. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 63:4, pages 217-232.
Crossref
Crossref
Peggy Bosch, Maurits van den Noort, Heike Staudte & Sabina Lim. (2015) Schizophrenia and Depression: A systematic Review of the Effectiveness and the Working Mechanisms Behind Acupuncture. EXPLORE 11:4, pages 281-291.
Crossref
Crossref
Na-Young Kim, Hyu-Jung Huh & Jeong-Ho Chae. (2015) Effects of religiosity and spirituality on the treatment response in patients with depressive disorders. Comprehensive Psychiatry 60, pages 26-34.
Crossref
Crossref
Hyu Jung HuhSang Bin HanYe Na ParkJeong-Ho Chae. (2015) Clinical Implication of Meditation in Psychiatry : Focused on Mindfulness Meditation. Journal of Korean Neuropsychiatric Association 54:4, pages 406.
Crossref
Crossref
Manisha Madhoo, Richard SE Keefe, Robert M Roth, Angelo Sambunaris, James Wu, Madhukar H Trivedi, Colleen S Anderson & Robert Lasser. (2013) Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder. Neuropsychopharmacology 39:6, pages 1388-1398.
Crossref
Crossref
Luke A. Probst & Jeni L. Burgess. 2014. Functional Symptoms in Pediatric Disease. Functional Symptoms in Pediatric Disease
373
416
.
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
155
250
.
Martin Lieb, Rainer Rupprecht & Thomas C. Baghai. (2012) Für jeden Patienten den optimalen Wirkstoff finden. NeuroTransmitter 23:12, pages 26-38.
Crossref
Crossref
Jung-Ah Min, Na-Bin Lee, Chang-Uk Lee, Chul Lee & Jeong-Ho Chae. (2012) Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression. Journal of Affective Disorders 137:1-3, pages 61-69.
Crossref
Crossref
Nadia Iovieno, Adrienne van Nieuwenhuizen, Alisabet Clain, Lee Baer & Andrew A. Nierenberg. (2011) Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. Depression and Anxiety 28:2, pages 137-144.
Crossref
Crossref
Sidney H. Kennedy & Sakina Rizvi. (2009) Sexual Dysfunction, Depression, and the Impact of Antidepressants. Journal of Clinical Psychopharmacology 29:2, pages 157-164.
Crossref
Crossref
Johannes M. Hennings, Toshimi Owashi, Elisabeth B. Binder, Sonja Horstmann, Andreas Menke, Stefan Kloiber, Tatjana Dose, Bastian Wollweber, Derek Spieler, Thomas Messer, Rita Lutz, Heike Künzel, Thomas Bierner, Thomas Pollmächer, Hildegard Pfister, Thomas Nickel, Annette Sonntag, Manfred Uhr, Marcus Ising, Florian Holsboer & Susanne Lucae. (2009) Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research 43:3, pages 215-229.
Crossref
Crossref
Magnus Lekman, Silvia Paddock & Francis J. McMahon. (2012) Pharmacogenetics of Major Depression. Molecular Diagnosis & Therapy 12:5, pages 321-330.
Crossref
Crossref
Magnus Lekman, Gonzalo Laje, Dennis Charney, A. John Rush, Alexander F. Wilson, Alexa J.M. Sorant, Robert Lipsky, Stephen R. Wisniewski, Husseini Manji, Francis J. McMahon & Silvia Paddock. (2008) The FKBP5-Gene in Depression and Treatment Response—an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biological Psychiatry 63:12, pages 1103-1110.
Crossref
Crossref
Stuart A. Montgomery. (2006) Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist. European Neuropsychopharmacology 16, pages S633-S638.
Crossref
Crossref